These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 18637271)

  • 1. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
    Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
    Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
    van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
    Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
    Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
    Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs.
    So AY; Jung JW; Lee S; Kim HS; Kang KS
    PLoS One; 2011 May; 6(5):e19503. PubMed ID: 21572997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.
    Kuzmichev A; Margueron R; Vaquero A; Preissner TS; Scher M; Kirmizis A; Ouyang X; Brockdorff N; Abate-Shen C; Farnham P; Reinberg D
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):1859-64. PubMed ID: 15684044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
    Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
    Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation between EZH2, NSPc1-mediated histone H2A ubiquitination and Dnmt1 in HOX gene silencing.
    Wu X; Gong Y; Yue J; Qiang B; Yuan J; Peng X
    Nucleic Acids Res; 2008 Jun; 36(11):3590-9. PubMed ID: 18460542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIRT1 affects DNA methylation of polycomb group protein target genes, a hotspot of the epigenetic shift observed in ageing.
    Wakeling LA; Ions LJ; Escolme SM; Cockell SJ; Su T; Dey M; Hampton EV; Jenkins G; Wainwright LJ; McKay JA; Ford D
    Hum Genomics; 2015 Jun; 9(1):14. PubMed ID: 26104761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
    Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
    Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of E-cadherin by the polycomb group protein EZH2 in cancer.
    Cao Q; Yu J; Dhanasekaran SM; Kim JH; Mani RS; Tomlins SA; Mehra R; Laxman B; Cao X; Yu J; Kleer CG; Varambally S; Chinnaiyan AM
    Oncogene; 2008 Dec; 27(58):7274-84. PubMed ID: 18806826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer.
    Kobayashi Y; Absher DM; Gulzar ZG; Young SR; McKenney JK; Peehl DM; Brooks JD; Myers RM; Sherlock G
    Genome Res; 2011 Jul; 21(7):1017-27. PubMed ID: 21521786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma.
    Yonemitsu Y; Imazeki F; Chiba T; Fukai K; Nagai Y; Miyagi S; Arai M; Aoki R; Miyazaki M; Nakatani Y; Iwama A; Yokosuka O
    Hum Pathol; 2009 Sep; 40(9):1304-11. PubMed ID: 19386347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma.
    Sasaki M; Ikeda H; Itatsu K; Yamaguchi J; Sawada S; Minato H; Ohta T; Nakanuma Y
    Lab Invest; 2008 Aug; 88(8):873-82. PubMed ID: 18591938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells.
    Fiskus W; Buckley K; Rao R; Mandawat A; Yang Y; Joshi R; Wang Y; Balusu R; Chen J; Koul S; Joshi A; Upadhyay S; Atadja P; Bhalla KN
    Cancer Biol Ther; 2009 May; 8(10):939-50. PubMed ID: 19279403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.
    Ren G; Baritaki S; Marathe H; Feng J; Park S; Beach S; Bazeley PS; Beshir AB; Fenteany G; Mehra R; Daignault S; Al-Mulla F; Keller E; Bonavida B; de la Serna I; Yeung KC
    Cancer Res; 2012 Jun; 72(12):3091-104. PubMed ID: 22505648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis.
    Sasaki M; Yamaguchi J; Itatsu K; Ikeda H; Nakanuma Y
    J Pathol; 2008 Jun; 215(2):175-83. PubMed ID: 18393368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyltransferase expression and tumor suppressor gene methylation in sporadic and familial colorectal cancer.
    Joensuu EI; Nieminen TT; Lotsari JE; Pavicic W; Abdel-Rahman WM; Peltomäki P
    Genes Chromosomes Cancer; 2015 Dec; 54(12):776-87. PubMed ID: 26305882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer.
    Yu J; Cao Q; Yu J; Wu L; Dallol A; Li J; Chen G; Grasso C; Cao X; Lonigro RJ; Varambally S; Mehra R; Palanisamy N; Wu JY; Latif F; Chinnaiyan AM
    Oncogene; 2010 Sep; 29(39):5370-80. PubMed ID: 20622896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma.
    Avissar-Whiting M; Koestler DC; Houseman EA; Christensen BC; Kelsey KT; Marsit CJ
    Epigenetics; 2011 Jun; 6(6):703-9. PubMed ID: 21610323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.